Singapore: Australian drug delivery technology company, Phosphagenics, will be returning to the clinic with its oxycodo...
The drug delivery technology landscape is rapidly evolving with new classes of pharmaceuticals and biologics fuelling th...
Singapore: Australia based pharmacuetical company, Starpharma, has appointed Mr Robert Thomas to the Board as a non-exec...
Singapore: Australia's Balnaves Foundation has donated $450,000 to the University of Sydney's medical school to help pro...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), and Helsinn, a Swiss group fo...
Singapore: Two approved drugs, an antifungal and a steroid, may potentially take on new roles as treatments for multiple...
Singapore: A group of researchers from Institute of Bioengineering and Nanotechnology (IBN) is using green tea ingredien...
Singapore: Singapore and Scotland based TauRx Pharmaceuticals, a clinical-stage biopharmaceutical company developing a n...
Singapore: Phase II clinical trials by scientists from the National Institute of Allergy and Infectious Diseases (NIAID)...
Singapore: Daiichi Sankyo is going to establish a new company named Orphan Disease Treatment Institute, along with Innov...
Singapore: Sinovac Biotech, a leading China-based vaccine manufacturer, has been selected by the Jiangsu Centers for Dis...
Sydney-headquartered Regeneus announced the completion of enrolment of all 20 patients in the STEP trial. Further, a rev...
Singapore: Pfizer's high hopes for its JAK3 (Janus kinase) inhibitor, tofacitinib (tasocitinib, CP-690550), now branded ...
Singapore: Ampio Pharmaceuticals has taken its candidate NCE001 from its proprietary methylphenidate derivatives family ...
Singapore: The US FDA Cardiovascular and Renal Drugs Advisory Committee has disapproved Japan-based Otsuka Pharmaceutic...
Singapore: Global pharmaceutical company, Pfizer, and Japanese firm, Kyowa Hakko Kirin, are jointly assessing the therap...
Singapore: The Network Verification Challenge has generated a comprehensive set of biological models relevant to chroni...
Singapore: Australia-based Prana Biotechnology has achieved positive result in its phase II clinical trial investigating...
